Cancer treatment

Michael Snyder, seated, received the first-ever dose of a targeted cancer therapy drug developed by Theratecnologies, a Canadian biopharmaceutical company at Gettysburg Cancer Center (GCC). Pictured standing behind him are GCC employees Terry Burke, clinical research resident nurse; Vanessa Warner, clinical research coordinator; Satish Shah, medical director; and Domenic Borro, director of operations.

For five years, Michael Snyder has been battling prostate cancer. Each time he thinks he has it beat, new symptoms emerge. With every new treatment comes more painful side effects.

“I’ve tried several different chemotherapies and every time we try something, it works for a while, my cancer mutates and then it stops working,” he said.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.